President and CEO
Catalent Pharma Solutions
John Chiminski was named President and Chief Executive Officer of Catalent, Inc. in March 2009 and appointed Chairman of the Catalent Board in October 2016.
He joined Catalent after more than 20 years at GE Healthcare where he held a number of senior leadership roles. From 2007 until he left in 2009, Mr. Chiminski served as President and CEO of GE Medical Diagnostics, a global business with sales of $1.9 billion. From 2005 to 2007, he served as Vice President and General Manager of GE Healthcare’s global magnetic resonance business, and from 2001 to 2005, Mr. Chiminski served as Vice President and General Manager of Global Healthcare Services. Earlier in his career at GE, Mr. Chiminski held a series of cross-functional leadership positions in both operations and engineering, including a GE Medical Systems assignment in France.
Mr. Chiminski partnered with the PE firm Blackstone to complete a carve-out of the Catalent business from Cardinal Health and transform it to its current position as a market leader in pharma services. Included in that transformation was a successful IPO in 2014 that raised over $1 billion.
Mr. Chiminski holds a bachelor’s from Michigan State University and master’s from Purdue University, both in electrical engineering, as well as a master’s in management from the Kellogg School of Management at Northwestern University. In 2012, he received a Distinguished Engineering Alumni award from Purdue for his record of accomplishments.
Mr. Chiminski has a diversified medical diagnostics and pharmaceutical background that includes supply chain, operations, research and development, and services with a track record of growing global businesses.
Married with three children, Mr. Chiminski resides in Newtown, Pennsylvania.